Carregant...
Rasagiline and Rapid Symptomatic Motor Effect in Parkinson’s Disease: Review of Literature
Rasagiline is a monoamine oxidase type-B inhibitor used as monotherapy or in addition to levodopa in the treatment of Parkinson’s disease. Once daily administration of rasagiline makes it easy to use, and allows good compliance by patients and adherence to therapy. Several multicenter studies have n...
Guardat en:
| Publicat a: | Neurol Ther |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Healthcare
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381918/ https://ncbi.nlm.nih.gov/pubmed/26000219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-013-0014-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|